FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3127720839> ?p ?o ?g. }

• W3127720839 endingPage "748" @default.
• W3127720839 startingPage "741" @default.
• W3127720839 abstract "Purpose To evaluate the cost-effectiveness of endocrine therapy (ET), radiation therapy (XRT), and combination ET + XRT as post-surgical treatment for older women with early-stage breast cancer from the societal perspective. Methods We constructed a Markov state-transition model consisting of three mutually exclusive health-states: Disease-Free, Recurrence, or Death. Osteoporotic fracture, radiation-induced breast fibrosis, and radiation pneumonitis were modeled as treatment-related adverse events (AEs). Cancer registry-linked-Medicare data were used to assess probability of recurrence and total costs, after propensity adjustment to account for treatment selection, among women aged >65 years diagnosed with estrogen receptor positive or progesterone receptor positive (ER+/PR+) breast cancer receiving ET, XRT, or ET + XRT in 2007–2011. Following randomized controlled trials, overall survival was assumed equivalent, but locoregional recurrence varied. Indirect costs and health-state utilities were literature-driven and varied in sensitivity analyses. Costs and outcomes were discounted at 3% annually. Results In a cohort of 10,000 women over ten years, we estimated 1620 total recurrences in the ET-only group, 1296 in the XRT-only group, and 1076 with ET + XRT. Compared to ET-only, the base-case incremental cost-effectiveness ratio (ICER) was $10,826 per quality-adjusted life-year (QALY)-gained for XRT-only and $26,834/QALY-gained for ET + XRT. Similarities in cost and effectiveness between treatments led to highly sensitive results. We also present clinically-relevant patient preference scenarios for recurrence risk-averse patients and near-term AE risk-averse patients. Conclusions The cost-effectiveness of regimens including ET and/or XRT in older women with early-stage breast cancer is sensitive to small differences in costs, as well as risk of, and utilities associated with, locoregional recurrence, suggesting that patient preferences concerning treatment benefits and risks should be considered by physicians." @default.
• W3127720839 created "2021-02-15" @default.
• W3127720839 creator A5017584214 @default.
• W3127720839 creator A5023327962 @default.
• W3127720839 creator A5044678886 @default.
• W3127720839 creator A5060863301 @default.
• W3127720839 creator A5082312263 @default.
• W3127720839 creator A5091370504 @default.
• W3127720839 date "2021-06-01" @default.
• W3127720839 modified "2023-10-01" @default.
• W3127720839 title "Cost-effectiveness of endocrine therapy versus radiotherapy versus combined endocrine and radiotherapy for older women with early-stage breast cancer" @default.
• W3127720839 cites W1861968279 @default.
• W3127720839 cites W1880798787 @default.
• W3127720839 cites W1983930571 @default.
• W3127720839 cites W2003042452 @default.
• W3127720839 cites W2006131871 @default.
• W3127720839 cites W2026157838 @default.
• W3127720839 cites W2036193982 @default.
• W3127720839 cites W2043363204 @default.
• W3127720839 cites W2044658894 @default.
• W3127720839 cites W2065575837 @default.
• W3127720839 cites W2067598506 @default.
• W3127720839 cites W2069940712 @default.
• W3127720839 cites W2079718947 @default.
• W3127720839 cites W2087372716 @default.
• W3127720839 cites W2098112001 @default.
• W3127720839 cites W2104793011 @default.
• W3127720839 cites W2121322081 @default.
• W3127720839 cites W2122428334 @default.
• W3127720839 cites W2125979795 @default.
• W3127720839 cites W2128585633 @default.
• W3127720839 cites W2150268143 @default.
• W3127720839 cites W2159427817 @default.
• W3127720839 cites W2164654252 @default.
• W3127720839 cites W2166535194 @default.
• W3127720839 cites W2166568742 @default.
• W3127720839 cites W2169031890 @default.
• W3127720839 cites W2194721905 @default.
• W3127720839 cites W2314200711 @default.
• W3127720839 cites W2510027037 @default.
• W3127720839 cites W2519603001 @default.
• W3127720839 cites W2591749194 @default.
• W3127720839 cites W2792879150 @default.
• W3127720839 doi "https://doi.org/10.1016/j.jgo.2021.01.004" @default.
• W3127720839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33558179" @default.
• W3127720839 hasPublicationYear "2021" @default.
• W3127720839 type Work @default.
• W3127720839 sameAs 3127720839 @default.
• W3127720839 citedByCount "3" @default.
• W3127720839 countsByYear W31277208392021 @default.
• W3127720839 countsByYear W31277208392023 @default.
• W3127720839 crossrefType "journal-article" @default.
• W3127720839 hasAuthorship W3127720839A5017584214 @default.
• W3127720839 hasAuthorship W3127720839A5023327962 @default.
• W3127720839 hasAuthorship W3127720839A5044678886 @default.
• W3127720839 hasAuthorship W3127720839A5060863301 @default.
• W3127720839 hasAuthorship W3127720839A5082312263 @default.
• W3127720839 hasAuthorship W3127720839A5091370504 @default.
• W3127720839 hasConcept C112930515 @default.
• W3127720839 hasConcept C121608353 @default.
• W3127720839 hasConcept C126322002 @default.
• W3127720839 hasConcept C143998085 @default.
• W3127720839 hasConcept C146357865 @default.
• W3127720839 hasConcept C151730666 @default.
• W3127720839 hasConcept C168563851 @default.
• W3127720839 hasConcept C197934379 @default.
• W3127720839 hasConcept C29456083 @default.
• W3127720839 hasConcept C3019080777 @default.
• W3127720839 hasConcept C509974204 @default.
• W3127720839 hasConcept C530470458 @default.
• W3127720839 hasConcept C64332521 @default.
• W3127720839 hasConcept C71924100 @default.
• W3127720839 hasConcept C72563966 @default.
• W3127720839 hasConcept C86803240 @default.
• W3127720839 hasConceptScore W3127720839C112930515 @default.
• W3127720839 hasConceptScore W3127720839C121608353 @default.
• W3127720839 hasConceptScore W3127720839C126322002 @default.
• W3127720839 hasConceptScore W3127720839C143998085 @default.
• W3127720839 hasConceptScore W3127720839C146357865 @default.
• W3127720839 hasConceptScore W3127720839C151730666 @default.
• W3127720839 hasConceptScore W3127720839C168563851 @default.
• W3127720839 hasConceptScore W3127720839C197934379 @default.
• W3127720839 hasConceptScore W3127720839C29456083 @default.
• W3127720839 hasConceptScore W3127720839C3019080777 @default.
• W3127720839 hasConceptScore W3127720839C509974204 @default.
• W3127720839 hasConceptScore W3127720839C530470458 @default.
• W3127720839 hasConceptScore W3127720839C64332521 @default.
• W3127720839 hasConceptScore W3127720839C71924100 @default.
• W3127720839 hasConceptScore W3127720839C72563966 @default.
• W3127720839 hasConceptScore W3127720839C86803240 @default.
• W3127720839 hasFunder F4320306095 @default.
• W3127720839 hasFunder F4320306890 @default.
• W3127720839 hasIssue "5" @default.
• W3127720839 hasLocation W31277208391 @default.
• W3127720839 hasOpenAccess W3127720839 @default.
• W3127720839 hasPrimaryLocation W31277208391 @default.
• W3127720839 hasRelatedWork W1963763723 @default.
• W3127720839 hasRelatedWork W2016681914 @default.

• next